{"text": "almost 36,000 bottles of prescription eye drops have been recalled after they were found to contain printer ink . a product recall of eye drops has been issued after nearly 36,000 bottles were found to contain printer ink . bausch and lomb , manufacturers of the prescription eye drops , has sent letters to doctors and chemists ordering the return of 35,800 . the company , one of the biggest eye-care firms in the world , has asked for the 1,780 batches - which contain 20 bottles in each - to be returned to their new york base after a manufacturing blunder . in a letter to hospitals and pharmacies , irene fazakerley , of the scottish government 's health department , said : ` bausch and lomb is recalling the batch because black particles have been identified in some packs . ` initial investigations suggest that the contaminant is printing ink , in which case we understand that the risk of toxicity is low . ` no other batches of this or any other product are affected . ` healthcare professionals are asked to quarantine remaining stock and contact the wholesaler from which it was obtained to arrange uplift and replacement . ' a spokesman from the drug watchdog , the medicines and healthcare products regulatory agency -lrb- mhra -rrb- said : ` these eye drops are only used in hospitals and administered by medical professionals . ` we do n't anticipate that people will have them at home . ' eye drops . bausch and lomb , creator of the . iconic ray-ban sunglasses , claimed that no one had been harmed by the . botched lots of eye anaesthetic . a . spokeswoman said : ` bausch and lomb is conducting a voluntary recall of a . single lot of proxymetacaine 0.5 % minims eye drops solution . ` we chose to initiate this recall after confirming a report of the presence of foreign particles in a product from this single lot . ` no adverse events have been reported which have been attributed to the defective product in this single lot . no other lots have been affected . ` no other products in the minims range or other bausch and lomb products are affected by this action . ` we are working closely with the mhra to provide updated information regarding this recall action . ' an mhra spokesperson added : there is no evidence that any patients are experiencing any problems from these eye drops and testing has shown that there is a low risk of any patients having any adverse reactions . ` this affected batch is not being used and we have alerted doctors , nurses and other healthcare professionals about this issue . ` these eye drops are used as a local anaesthetic for eye procedures in hospital and are only used under the supervision of a qualified healthcare professional . ` people who are worried or who have concerns can speak to their doctor . '", "summary": " black particles have been identified in some packs .   doctors and chemists have received letters asking them to return packs sold by bausch and lomb .   manufacturer claims no one has been harmed . "}